Galectin-3
Device
Abbott Laboratories
Total Payments
$46,000
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $46,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $46,000 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Atherosclerosis Risk in Communities (ARIC) | Abbott Laboratories | $46,000 | 0 |
Top Doctors Receiving Payments for Galectin-3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houston, TX | $46,000 | 2 |
Ad
Manufacturing Companies
- Abbott Laboratories $46,000
Product Information
- Type Device
- Total Payments $46,000
- Total Doctors 0
- Transactions 2
About Galectin-3
Galectin-3 is a device associated with $46,000 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $46,000 was paid across 2 transactions to 0 doctors.
The most common payment nature for Galectin-3 is "Unspecified" ($46,000, 100.0% of total).
Galectin-3 is associated with 1 research study, including "Atherosclerosis Risk in Communities (ARIC)" ($46,000).